The role of percutaneous coronary intervention (PCI) in patients with ST elevation
myocardial infarction (STEMI) is clear (European Society of Cardiology STEMI Guideline …

Answer: The ORBITA trials focus on a specific aspect of the management of patients with
acute coronary syndrome: the benefit in terms of symptom relief of angina. 1, 2 The first …

Abstract Background The 2012 Guidelines for Diagnosis and Management of Patients with
Stable Ischemic Heart Disease recommend intensive antianginal and risk factor treatment …

Background: Revascularization is often performed in patients with stable ischemic heart
disease. However, whether revascularization reduces death and other cardiovascular …

PCI for stable angina | Nature Reviews Cardiology Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain …

Current medical practice is based on evidence-based medicine. The clinical guidelines
have this purpose to regulate both medical and surgical treatment. Coronary heart disease …

Cardiovascular diseases (CVDs) are the most common cause of death globally. In 2016, a
total of 17.9 million people died due to CVDs; of them, heart attack and stroke accounted for …

Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery
Disease Following the ISCHEMIA Trial? - PMC Back to Top Skip to main content NIH NLM …

Background The ISCHEMIA trial demonstrated that an initial invasive (INV) approach to
chronic coronary syndromes (CCS) results in an improvement in angina when compared to …

This review article summarizes key landmark trials that have shaped understanding of the
role of percutaneous coronary intervention (PCI) in stable coronary artery disease (CAD) …